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Background: Campylobacter jejuni strain 11168 was demonstrated to have a broad specificity for eukaryotic surface
glycosylation using glycan array analysis. The initial screen indicated that sialic acid and mannose are important
binding partners after environmental stress, while galactose and fucose structures are likely to be involved in
persistent infection.
Results: In this broader study, five additional human/clinical isolates and six chicken isolates were fully assessed to
determine their glycan binding capacity using an extended glycan array. C. jejuni 11168 was rescreened here due to
the presence of glycoaminoglycan (GAG) and other structures that were not available on our previous glycan array.
The current array analysis of additional C. jejuni strains confirmed the growth condition dependent differences in
glycan binding that was previously observed for C. jejuni 11168. We noted strain to strain variations, particularly for
the human isolates C. jejuni 520 and 81116 and the chicken isolate C. jejuni 331, with the majority of differences
observed in galactose, mannose and GAG binding. Chicken isolates were found to bind to a broader range of
glycans compared to the human isolates, recognising branched mannose and carageenan (red seaweed) glycans.
Glycan array data was confirmed using cell-based lectin inhibition assays with the fucose (UEA-I) and mannose
(ConA) binding lectins.
Conclusions: This study confirms that all C. jejuni strains tested bind to a broad range of glycans, with the majority
of strains (all except 81116) altering recognition of sialic acid and mannose after environmental stress. Galactose
and fucose structures were bound best by all strains when C. jejuni was grown under host like conditions
confirming the likelihood of these structures being involved in persistent infection.
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Glycan or carbohydrate based host-bacterial interactions
are crucial for the initiation of both disease and colonisa-
tion of many bacteria species [1-4]. Specifically, the ability
to recognise a broad range of host cell surface glycosylation
has been shown to be crucial for the adherence and infect-
ivity of C. jejuni [3,4]. In vivo, fucosylated glycans present
on human breast milk proteins and free fucosylated oligo-
saccharides can reduce the incidence of C. jejuni infections
in breastfeeding infants [5,6]. While in vitro, blocking the
surface glycans with lectins to fucosylated and terminal gal-
actose structures can completely inhibit the adherence of
C. jejuni to Caco-2 cells [3].* Correspondence: v.korolik@griffith.edu.au
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reproduction in any medium, provided the orGlycan array analysis of C. jejuni 11168 found that binding
of C. jejuni to mannosylated and sialylated glycoconjugates
was dependent on the growth or maintenance conditions of
the bacteria [3]. After exposure of C. jejuni to environmental
stress (normal oxygen and room temperature) the bacteria
were found to bind extensively to mannosylated and
sialylated glycoconjugates. This binding was eliminated
when the bacteria were grown under microaerobic condi-
tions at either 37°C or 42°C; at these conditions binding to
galactose and fucose predominated [3].
Within the Epsilon proteobacteria a complete spectrum
of glycans involved in host bacterial interactions has been
determined for Helicobacter pylori. Like C. jejuni, H. pylori
exhibits broad complexity in carbohydrate-binding specific-
ities. It has been proposed for H. pylori that initial interac-
tions with host tissues may be achieved through binding to
the normal gastric epithelium which expresses non-. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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through the action of the lectin BabA [2,7,8]. In addition,
persistence of H. pylori infection appears to be mediated
through the binding of the lectin SabA to the sialylated dis-
eased epithelium of the chronically infected stomach [2,8,9].
In contrast, the initial interactions for C. jejuni 11168, ap-
pear to be to highly sialylated and mannosylated structures
such as those found on human glycoprotein MUC1, abun-
dant in human intestinal mucosa [3,4,8,10]. While persistent
C. jejuni infection in crypts of the intestinal epithelium
seems to depend on fucose and galactose, structures more
readily found on the gel forming mucins such as MUC2
[3,4,8].
C. jejuni has a broad host range, infecting a wide range of
both avian and mammalian hosts. Within eukaryotes there
are numerous differences between the types of surface gly-
cans present with differences in sialic acids (Neu5Ac/
Neu5Gc) expressed, level and linkages type to fucose and
the degree of terminal α/β linkages to terminal galactose res-
idues [11-14]. C. jejuni can be either infectious or com-
mensal in different hosts, with disease typically observed in
mammals and commensal relationships with avian species.
Whether or not the host temperature or glycan expression
may play a role in this is still to be elucidated. In this study
we analysed the glycan binding profile of twelve strains of C.
jejuni isolated from human and avian hosts with differing in-
vasive profiles to determine if there are any glycan binding
differences between invasive and non-invasive C. jejuni.
Results
Glycan array analysis of C. jejuni strains
Glycan array screening was performed on C. jejuni strains
grown under different conditions to determine the glycan
binding specificity for each strain tested. Each of the twelve
C. jejuni strains was found to recognise a large variety of
glycoconjugates present on the array (Tables 1, 2, 3 and 4;
see Additional file 1: Table S1 for full list and structures of
glycans).
All but two of the strains, C. jejuni 331 and 520, bound
all galactose structures present on the array (Table 1). The
chicken isolate C. jejuni 331 recognised the least number
of terminal galactose structures only recognising 15 of the
24 printed structures. Of the nine terminal galactose
structures that C. jejuni 331 fails to recognise, seven are
disaccharides and no binding was observed to disaccha-
rides containing GalNAc residues. Human isolate C. jejuni
520 failed to bind two structures; one was asialo-GM1
(1 F) and a terminal α-1-4 linked galactose (1 K), both
these structures offer unique terminal glycans, with no
other glycan present on the array presenting the same
structure on the reducing end (Table 1).
Most variability was observed in binding to N-
acetylglucosamine (Table 2; 4A-4E), mannosylated (Table 2;
5A-5H) and sialylated (Table 3; 10A-11D) glycans, withdifferent strains recognising variable subsets of each of these
structures. Binding to mannose and sialic acid was consist-
ently growth condition dependent for the majority of strains
tested (10/12) with differential binding occurring depending
on whether the strains were grown under conditions mim-
icking different hosts (37/42°C with microaerobic condi-
tions) or environmentally exposed (room temperature with
normal oxygen; Tables 2 and 3).
Chitin structures (GlcNAcn; Table 2, 4A-4D) are present
on the array as a variable repeat length glycan (2–5 sugars
in length), with the recognition of these repeat lengths dif-
fering between strains tested. The non-invasive chicken
isolate 331 has a preference for the smaller repeats
(GlcNAc2-3; Table 2, 4A and B), while almost all other
strains preferentially bound to the larger fragments
(GlcNAc5; Table 2, 4D). C. jejuni 11168 was found not to
bind any of these structures.
Though sialic acid was in general only recognised under
conditions mimicking environmental stress there were sev-
eral sialylated structures that were also recognised by all C.
jejuni strains grow under host-like conditions. Typically
the sialylated structures recognised by C. jejuni grown
under host-like conditions were also fucosylated. The most
noteworthy was binding of the sialylated and fucosylated
structures, SialylLewis A and X (Table 3, 10A and B). Bind-
ing differences were observed for human isolates 351, 375
and 520 and chicken isolates 331, 434 and 506, however,
these differences could not be attributed to a specific host,
chicken or human. Also, C. jejuni strains 520 (human),
81116 (human) and 019 (chicken) were shown to bind at
least one non-fucoslylated sialic acid containing structure
when grown under host-like conditions. For C. jejuni 520
and 019 this structure is a complex, branched, N-linked
glycan that contains within its 11 residues; a mixture of si-
alic acid (terminal positions on the branches), galactose,
mannose and glucosamine linked directly to an asparagine.
Therefore, the binding of sialic acid by C. jejuni 520 and
019 to this structure may not be due to any specific recog-
nition of sialic acid under host-like growth conditions.
All C. jejuni strains widely recognised structures
containing fucose including the bianternary structure
present in the sialylated glycans (Table 3; 10D), with no
significant difference observed between the twelve
strains (data not shown; see Additional file 1: Table S1
for list of structures tested).
Numerous differences were observed for the binding
of glycoaminoglycans (GAGs) and related structures be-
tween the C. jejuni strains tested (Table 4). Recognition
of GAG structures has not previously been reported for
C. jejuni. We found that carageenan structures (red sea-
weed extract with structural similarities to GAGs) were
preferred by chicken isolates, with five of the six isolates
recognising these structures. Only C. jejuni 331 did not
bind to these structures (Table 4; 12A-F). Of the human
Table 1 Terminal galactose binding from the glycan array analysis of twelve C. jejuni strains
Glycan ID Human Chicken
11168 351 375 520 81116 81–176 331 008 019 108 434 506
RT 37 4 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42
1A + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
1B + + + + + + + + + + + + + + + + + + - - - + + + + + + + + + + + + + + +
1C + + + + + + + + + + + + + + + + + + - - - + + + + + + + + + + + + + + +
1D + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
1E + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
1 F + + + + + + + + + - - - + + + + + + + + + + + + + + + + + + + + + + + +
1G + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
1H + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
1I + + + + + + + + + + + + + + + + + + - - - + + + + + + + + + + + + + + +
1 J + + + + + + + + + + + + + + + + + + - - - + + + + + + + + + + + + + + +
1 K + + + + + + + + + - - - + + + + + + - - - + + + + + + + + + + + + + + +
1 L + + + + + + + + + + + + + + + + + + - - - + + + + + + + + + + + + + + +
1 M + + + + + + + + + + + + + + + + + + - - - + + + + + + + + + + + + + + +
1 N + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
1O + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
1P + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
2A + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
2B + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
2C + + + + + + + + + + + + + + + + + + - - - + + + + + + + + + + + + + + +
2D + + + + + + + + + + + + + + + + + + - - - + + + + + + + + + + + + + + +
2E + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
2 F + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
2G + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
2H + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Each of the strains were analysed at room temperature (left), 37°C (middle) and 42°C (right). Binding +; No binding -. See Additional file 1: Table S1 for full list of glycan names and structures. 1A Galβ1-3GlcNAc; 1B
Galβ1-4GlcNAc; 1C Galβ1-4Gal; 1D Galβ1-6GlcNAc; 1E Galβ1-3GalNAc; 1 F Galb1-3GalNAcβ1-4Galβ1-4Glc; 1G Galβ1-3GlcNAcβ1-3Galβ1-4Glc; 1H Galβ1-4GlcNAcβ1-3Galβ1-4Glc; 1I Galβ1-4GlcNAcβ1-6(Galβ1-4GlcNAcβ1-
3)Galβ1-4Glc; 1 J Galβ1-4GlcNAcβ1-6(Galβ1-3GlcNAcβ1-3)Galβ1-4Glc; 1 K Galα1-4Galβ1-4Glc; 1 L GalNAcα1-O-Ser; 1 M Galβ1-3GalNAcα1-O-Ser; 1 N Galα1-3Gal; 1O Galα1-3Galβ1-4GlcNAc; 1P Galα1-3Galβ1-4Glc; 2A




















Table 2 Glucosamine and mannose binding from the glycan array analysis of twelve C. jejuni strains
Glycan ID Human Chicken
11168 351 375 520 81116 81–176 331 008 019 108 434 506
RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42
4A - - - + - - - - - - - - + + + - - - + + + - - - - - - - - - - - - - - -
4B - - - + - - - - - - - - + + + - - - + + + - - - - - - - - - - - - - - -
4C - - - + - - - - - - - - + + + - - - - - - + + + - - - - - - - - - + + +
4D - - - + + + + + + + + + + + + + + + - - - + + + - - - - - - + + + + + +
4E - - - + + + + + + + + + + + + + + + - - - + + + - - - - - - + + + + + +
5A + + + + + + + + + + + + + + + + + + - - - + + + + + + + + + + + + + + +
5B + + + + + + + + + + + + + + + + + + - - - + + + + + + + + + + + + + + +
5C - - - + - - + - - + - - + + + + - - + + + + - - + - - + - - - - - - - -
5D - - - + - - + - - + - - + + + + - - - - - + - - + - - + - - - - - - - -
5E + - - + - - + - - + - - + + + + - - + + + + - - + - - + - - + - - + - -
5 F + - - + - - + - - + - - + + + + - - + + + + - - + - - + - - + - - + - -
5G + - - + + + + - - + - - + + + + - - + + + + - - + - - + + + + + + + + +
5H + - - + + + + - - + - - + + + + - - + + + + - - + - - + + + + + + + + +
Each of the strains were analysed at room temperature (left), 37°C (middle) and 42°C (right). Binding +; No binding -. 4A-4D are repeating N-Acetylglucosamine (GlcNAc) structures that increase in length from A-D
(4A GlcNAcβ1-4GlcNAc; 4B GlcNAcβ1-4GlcNAcβ1-4GlcNAc; 4C GlcNAcβ1-4GlcNAcβ1-4GlcNAcβ1-4GlcNAc; 4D GlcNAcβ1-4GlcNAcβ1-4GlcNAcβ1-4GlcNAcβ1-4GlcNAcβ1-4GlcNAc; 4E GlcNAcβ1-4MurNAc). 5A and B are
mannose containing GlcNAc structures (5A GlcNAcβ1-2Man; 5B GlcNAcβ1-2Manα1-6(GlcNAcβ1-2Manα1-3)Man), while 5C-5H are mannose of differing linkages and branch size (5C Manα1-2Man; 5D Manα1-3Man; 5E



















Table 3 Binding of sialylated structures from the glycan array analysis of twelve C. jejuni strains
Glycan ID Human Chicken
11168 351 375 520 81116 81–176 331 008 019 108 434 506
RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42
10A + - - + + + + + + + + + + - - + - - + + + + - - + - - + - - + + + + + +
10B + - - + + + + + + + + + + - - + - - + + + + - - + - - + - - + + + + + +
10C + - - + - - + - - + - - + + + + - - + - - + - - + - - + - - + - - + - -
10D + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
10 K + - - + - - + - - + - - + + + + - - + - - + - - + - - + - - + - - + - -
10 L + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - -
10 M + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - -
10 N + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - -
10O + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - -
10P + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - -
11A + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - -
11B + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - -
11C + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - - + - -
11D + - - + - - + - - + + + + - - + - - + - - + - - + - - + - - + - - + - -
Each of the strains were analysed at room temperature (left), 37°C (middle) and 42°C (right). Binding +; No binding -. See Additional file 1: Table S1 for full list and structures of glycans. 10A Neu5Acα2-3Galβ1-3(Fucα1-
4)GlcNAc; 10B Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAc; 10C Neu5Acα2-3Galβ1-3GlcNAcβ1-3Galβ1-4Glc; 10D Galβ1-4(Fucα1-3)GlcNAcβ1-6(Neu5Acα2-6Galβ1-4GlcNAcβ1-3)Galβ1-4Glc; 10 K Neu5Acα2-3Galβ1-4GlcNAc; 10 L
Neu5Acα2-6Galβ1-4GlcNAc; 10 M Neu5Acα2-3Galβ1-3GlcNAcβ1-3Galβ1-4Glc; 10 N Galβ1-3(Neu5Acα2-6)GlcNAcβ1-3Galβ1-4Glc; 10O Neu5Acα2-6Galβ1-4GlcNAcβ1-3Galβ1-4Glc; 10P Neu5Acα2-3Galβ1-3(Neu5Acα2-6)




















Table 4 Binding of GAG and GAG related structures from the glycan array analysis of twelve C. jejuni strains
Glycan ID Human Chicken
11168 351 375 520 81116 81–176 331 008 019 108 434 506
RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42 RT 37 42
12A + + + - - - - - - - - - + + + - - - - - - + + + + + + + + + + + + + + +
12B + + + - - - - - - - - - + + + - - - - - - + + + + + + + + + + + + + + +
12C + + + - - - - - - - - - + + + - - - - - - + + + + + + + + + + + + + + +
12D + + + - - - - - - - - - + + + - - - - - - + + + + + + + + + + + + + + +
12E + + + - - - - - - - - - + + + - - - - - - + + + + + + + + + + + + + + +
12 F + + + - - - - - - - - - + + + - - - - - - + + + + + + + + + + + + + + +
12G - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
12H - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
12I - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
12 J - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
12 K - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
12 L - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
12 M - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
12 N - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
12O - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
12P - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
13A - - - - - - - - - + + + + + + - - - - - - - - - - - - - - - - - - - - -
13B - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
13C - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
13D - - - - - - - - - - - - + + + - - - - - - - - - - - - - - - - - - - - -
13E - - - - - - - - - + + + + + + - - - + + + - - - - - - - - - - - - - - -
13 F + + + + + + + + + - - - + + + + + + - - - + + + - - - + + + + + + - - -
13G + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
13H + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
13I + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
13 J + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
13 K + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
13 L + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
13 M + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
13 N + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +



















Table 4 Binding of GAG and GAG related structures from the glycan array analysis of twelve C. jejuni strains (Continued)
13P + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
14A + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
14B + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
14C + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
14D + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
14E + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
14 F + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
14G + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
14H + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
14I + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Each of the strains were analysed at room temperature (left), 37°C (middle) and 42°C (right). Binding +; No binding -. 12A-12 F are Carrageenan repeats; 12G-13E are digested Glycoaminoglycans in their most basic
non-repeating unit (12G ΔUA-2S → GlcNS-6S Na4 (I-S); 12H ΔUA → GlucNS-6S Na3 (II-S); 12I ΔUA→ 2S-GlcNS Na3 (III-S); 12 J ΔUA→ 2S-GlcNAc-6S Na3 (I-A); 12 K ΔUA→ GlcNAc-6S Na2 (II-A); 12 L ΔUA→ 2S-GlcNAc
Na2 (III-A); 12 M ΔUA → GlcNAc Na (IV-A); 12 N ΔUA→ GalNAc-4S Na2 (ΔDi-4S); 12O ΔUA → GalNAc-6S Na2 (ΔDi-6S); 12P ΔUA → GalNAc-4S,6S Na3 (ΔDi-disE); 13A ΔUA→ 2S-GalNAc-4S Na2 (ΔDi-disB); 13B ΔUA→
2S-GalNAc-6S Na3 (ΔDi-disD); 13C ΔUA→ 2S-GalNAc-4S-6S Na4 (ΔDi-tisS); 13D ΔUA → 2S-GalNAc-6S Na2 (ΔDi-UA2S); 13E ΔUA → GlcNAc Na (ΔDi-HA); 13 F-14I are larger repeating Glycoaminoglycans ranging from
4mers to 1.6MDa in size (13 F (GlcAβ1-3GlcNAcβ1-4)n (n = 4); 13G (GlcAβ1-3GlcNAcβ1-4)n (n = 8); 13H. (GlcAβ1-3GlcNAcβ1-4)n (n = 10); 13I (GlcAβ1-3GlcNAcβ1-4)n (n = 12); 13 J (GlcA/IdoAα/β1-4GlcNAcα1-4)n (n = 200);
13 K (GlcA/IdoAβ1-3(±4/6S)GalNAcβ1-4)n (n < 250); 13 L ((±2S)GlcA/IdoAα/b1-3(±4S)GalNAcβ1-4)n (n < 250);13 M (GlcA/IdoAβ1-3(±6S)GalNAcβ1-4)n (n < 250); 13 N (GlcAβ1-3GlcNAcβ1-4)n (n = 4); 130 (GlcAβ1-
3GlcNAcβ1-4)n (n = 6); 13P (GlcAβ1-3GlcNAcβ1-4)n (n = 8); 14A (GlcAβ1-3GlcNAcβ1-4)n (n = 10); 14B (GlcAβ1-3GlcNAcβ1-4)n (n = 12); 14C (GlcAβ1-3GlcNAcβ1-4)n (n = 14); 14D(GlcAβ1-3GlcNAcβ1-4)n (n = 16); 14E
(GlcAβ1-3GlcNAcβ1-4)n (30000 Da); 14 F (GlcAβ1-3GlcNAcβ1-4)n (107000 Da); 14G (GlcAβ1-3GlcNAcβ1-4)n (190000 Da); 14H (GlcAβ1-3GlcNAcβ1-4)n (220000 Da); 14I (GlcAβ1-3GlcNAcβ1-4)n (1600000 Da); 14 J (GlcA/



















Figure 1 Lectin and free glycan competition assays. Comparison
between normal adherence (100%) and inhibition with lectin or
glycan pre-treatment. The smaller the bar the less C. jejuni adhered
in the presence of the lectin/glycan. A. ConA competition of C. jejuni
adherence to Caco-2 cells; B. UEA-I competition of C. jejuni
adherence to Caco-2 cells. C. Competion assays with free glycans
with C. jejuni 11168 and 331 adhering to Caco-2 cells.
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http://www.biomedcentral.com/1471-2180/13/228isolates, only C. jejuni 11168 and 81116 bound to the
carageenan structures. C. jejuni 81116 was the only
strain that bound with any consistency to the enzymati-
cally digested GAG disaccharide fragments (Table 4;
12G-13H). However, all strains of C. jejuni tested bound
to hyaluronin, chondrotin, heparin and dermatin.
Lectin and glycan competition adherence assays
As previously shown with C. jejuni 11168, lectins that
recognise structures similar or identical to those
recognised by C. jejuni, can be used to inhibit adherence
to the surface of Caco-2 cells [3]. For the adherence in-
hibition assays, using both lectins and free glycans,
C. jejuni was grown at 37°C in a microaerobic environ-
ment, mimicking one of the growth conditions used
in glycan arrays assays. Two lectins were tested; ConA
(mannose binding lectin) and UEA-I (fucose binding
lectin).
As predicted from the array results, ConA had the
greatest inhibitory effects on the adherence of C. jejuni
81116 and 331 with reductions of more than 70%, no
significant difference was observed for the other strains
tested (Figure 1A). UEA-I resulted in significant reduc-
tion in adherence for all strains tested but did not affect
the adherence of the control E. coli DH5a strain
(Figure 1B).
Free glycans were also tested on the adherence of two
C. jejuni strains; the clinical isolate 11168 and the
chicken isolate 331. Using 100 μM of free blood group
antigens, A blood group trisaccharide (glycan 7 K on the
array) and the H disaccharide (O-blood group antigen;
glycan 7 F on the array), resulted in the significant de-
crease of adherence of both C. jejuni 11168 (P < 0.05)
and 331 (P < 0.05) to Caco-2 cells (Figure 1C). Free man-
nose (α1-2 Mannobiose at 100 μM; glycan 5C on the
array) had no effect on the binding of C. jejuni 11168 to
Caco-2 cells but did significantly reduce the adherence
of C. jejuni 331 (P < 0.05; Figure 1C). This result is in
agreement with the array data, with both strains binding
blood group antigens but only C. jejuni 331 recognising
mannose under the condition tested (Table 2).
Discussion
All C. jejuni strains tested in this study showed remark-
able similarity for the general types of glycan structures
that were recognised. Looking globally at the total array,
C. jejuni behaves as a species with little variation, each
strain bound to both α and β galactose, terminal and
subterminal fucosylated structures and to a subset of
glycoaminoglycans at all conditions tested. All strains
also exhibited binding to a broader range of glycans
when placed under environmental stress. Only chitin, a
common insect and crustacean glycan, showed major
differences when viewed from a global perspective, withone strain, C. jejuni 11168, failing to recognise any chitin
molecule. No major difference was observed between C.
jejuni strains isolated from different hosts.
The possibility of galactose and fucose being involved
in the persistent colonisation of C. jejuni [3,4] is sup-
ported by the interactions observed in this study. All
twelve strains, whether isolated from avian or clinical
sources, bound broadly to uncapped galactose structures
and fucosylated structures. These results were confirmed
by inhibition of adherence to cells blocked by competing
C. jejuni adherence with UEA-I.
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one clinical isolate (520) showed variability in the galactose
structures bound. Of interest is the broad specificity of all
the C. jejuni strains for galactose and fucosylated structures.
Only strain, C. jejuni 520, showed binding differences based
on linkage specificity with Galβ1-3GalNAc (asialo-GM1 1 F)
and terminal α-1-4 linked di-galactose (1 K) glycan struc-
tures not being recognised.
The fact that C. jejuni recognises a broad range of both
α and β linked galactose may offer some explanation for
such a broad host range, as might the lack of specificity for
linkage and position of fucose in fucosylated structures. α-
linked galactose are not common in humans but are com-
mon in many other mammals and avian species [13-17].
Some strains of C. jejuni are known to produce the P-
antigen, a terminal α-linked galactose, as a part of their
LOS structure to mimic the glycans of potential avian and
non-human mammalian hosts [13,18]. β-linked galactose
structures are common to all animals known to be infected
with C. jejuni. The fact that C. jejuni recognises both α and
β linked galactose indicates either a broad specificity gal-
actose binding lectin or two or more lectins with restricted
specificity. As binding to these different galactose struc-
tures is not preferential under any condition tested, it is
likely that a single yet to be identified broad specificity
glactose binding lectin is expressed by C. jejuni.
Fucose is a known chemoattractant of C. jejuni but the
binding observed in our glycan array analysis is unlikely
to be related to the periplasmic receptors for chemo-
taxis. Fucose surface expression in humans is dependent
on a range of fucosyltransferases that can be differen-
tially expressed both throughout tissues and between in-
dividuals resulting in differential fucosylation between
tissue types or differential fucosylation of the same tissue
types when comparing two nonrelated individuals. As
C. jejuni has no preference for linkage or location it is
likely that either the same protein that recognises galact-
ose is binding fucosylated structures but ignoring the
presence of fucose or that C. jejuni has a broad specifi-
city fucose binding lectin.
Binding to N-acetylglucosamine structures was differen-
tial between strains with three strains not recognising
GlcNAc structures at all (C. jejuni 11168, 019 and 108).
Typically among strains that did recognise GlcNAc struc-
tures the longer repeats were preferred. Only C. jejuni 331
(under all conditions), 81116 (under all conditions) and
351 (under environmental conditions) recognised the short
repeats. Chitin a common glycoconjugate found in insects
and crustaceans is comprised of repeating GlcNAc resi-
dues. It is possible that C. jejuni strains that recognise
GlcNAc structures may use insects as vectors as described
by Hald et al. [19], or that strains with GlcNAc recognition
can better infect crustaceans to survive and propagate in
fresh water ponds and streams [19,20]. Chitin recognitionmay therefore be important for environmental survival and
spread, also offering advantages for re-infection of more
preferred avian or mammalian hosts.
In line with previously reported data [3], mannose was
recognised more often after environmental stress by most
of the C. jejuni strains tested. C. jejuni 331 and 81116
were the only strains to recognise a wide variety of man-
nose structures under all growth/maintenance conditions.
Several other strains, more common to the chicken iso-
lates tested (Human isolate: C. jejuni 351; Chicken iso-
lates: C. jejuni 108, 434 and 506), also recognised some of
the branched mannose structures under all conditions
tested. Branched mannose is far more common in com-
plex N-linked glycans found on many different cell surface
proteins. These branched mannose structures are typically
capped by other sugars including Glc/GlcNAc, Gal/
GalNAc and sialic acid implying that either these interac-
tions are through subterminal binding proteins that can
recognise capped structures or are not biologically rele-
vant to infection/colonisation. From the binding profile of
C. jejuni to the complex sialylated structure, 11D, it appears
in all cases but C. jejuni 108 that subterminal recognition
of mannose in complex N-linked glycans can be ruled out.
Similar to C. jejuni binding to mannose, sialic acid rec-
ognition was only observed following a period of envir-
onmental stress, with all the C. jejuni strains tested
exhibiting significantly more binding to sialylated gly-
cans when maintained under normal atmosphere and at
room temperature. This indicates that an adhesion/lectin
able to bind sialylated glycans is regulated by the expos-
ure of C. jejuni to environmental stress. As yet, no such
protein has been elucidated in C. jejuni. Sialic acid is a
common glycan present on multiple cell types and is
typically the terminal sugar presented. In the intestines
MUC1 is the most heavily sialylated protein present,
however, MUC1 acts as a decoy receptor for bacteria
and other viral and microbial infecting agents [10].
When MUC1 is bound by pathogens it is released from
the cell surface and allows the pathogen to be excreted
into the environment through the lumen [10]. A number
of pathogens, including C. jejuni, are more infectious,
have a lower infectious dose or get into deeper tissues
faster when administered to MUC1−/− mice [10].
Of the few sialylated structures that were bound more
broadly by C. jejuni, 10A (C. jejuni strains 351, 375, 520,
331, 434, 506), 10B (C. jejuni strains 351, 375, 520, 331,
434, 506) and 10D (all strains tested), are all fucosylated,
indicating that the binding to these glycans may be more
due to fucose than to sialic acid. C. jejuni 81116, once
again, recognised a wider variety of sialic acid containing
structures than the other C. jejuni strains tested, binding
to α2-3 linked sialylactosamine structures. C. jejuni 81116
has a vastly different cell surface glycosylation profile than
other C. jejuni producing larger non-sialylated LPS like
Table 5 Bacterial strains used in this study
Strain Invasive Source
Human +/−




81116 + D. Newell
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jejuni [21]. It may be interesting to speculate that surface
glycosylation can play a role in the inhibition of the bind-
ing of C. jejuni to sialylated glycans, particularly through
charge-charge repulsion. Sialic acid is a negatively charged
sugar and C. jejuni strains such as 11168 are known to
have surface glycosylation that contains sialic acid [22,23].
Of the strains that bound to sialyllewis structures (10A
and B), we have recently shown that, C. jejuni 351, 375
and 331, do not have surface sialylation [24], indicating
these strains may be able to recognise the underlying fu-
cose. We are yet to confirm the sialylation levels of C.
jejuni strains 434 and 506. C. jejuni 520 seems to be a spe-
cial case as the LOS it produces appears to be very
heterogenous [24]. We have shown using lectin array and
surface plasmon resonance that a proportion of the LOS
produced by this strain is completely non-sialylated at all
growth conditions tested [24]. It is therefore possible that
sufficient C. jejuni 520 was present in the assay with low
or no surface sialylation allowing for recognition of the
underlying branched fucose.
Glycoaminoglycan binding by C. jejuni on glycan ar-
rays has not previously been reported. C. jejuni in gen-
eral preferred larger GAG fragments, with the most
consistent binding observed to full length GAGs of up
to 1.6MDa. GAGs are common extracellular matrix
components and are expressed in on the surface of a
broad range of cells [25-27]. GAGs are also known to as-
sociate with known cell surface targets of C. jejuni in-
cluding fibronectin [25-27]. Once more 81116 had the
broadest recognition for GAG and related structures
recognising all the structures present on our array.
The non-invasive C. jejuni strain 331 had a preference
for longer, branched galactose structures and was less
likely to associate with disaccharides or terminal N-
Acetylgalactosamine structures. This is of interest as C.
jejuni 331 is known to be a strong chicken coloniser,
capable of out competing other C. jejuni strains in co-
infection studies and has been proposed as a potential
non-virulent bioreplacement bacteria [28,29]. It is pos-
sible that the lack of binding to disaccharide and small
sugar subunits by C. jejuni 331 may offer a competitive
advantage, allowing 331 to better colonise the intestinal
crypts by ignoring smaller sugars in the lumen. Mono-
and di-saccharides are common products from the activ-
ity of glycosidases in the intestinal tract of animals. This
makes mono- and di-saccharides potential decoy recep-
tors for C. jejuni in the chicken gut and as such, bacteria
that do not bind to smaller sugars would potentially
have a competitive advantage.
Conclusions
The conclusions drawn from the initial screening of
C. jejuni 11168 on our glycan array [3] have in the mainbeen confirmed by the screening of additional strains.
Sialic acid and mannose still appear to be the general
structures recognised after environmental stress, appea-
ring to be important for initial host pathogen inter-
actions. Galactose and fucose structures still appear to
be crucial for the persistence of infection. Little differ-
ence is seen between the isolates from clinical or chicken
hosts, with the exception of carageenan and branched
mannose binding, with both more likely to be recognised
by chicken isolates than those isolated from humans.
This study increases the understanding of C. jejuni gly-
can recognition and provides a model for the study of
complex glycan recognition from a number of other yet
to be screened bacterial species.
Methods
Bacterial strains and growth conditions
The strains used in this study can be found in Table 5.
Bacteria were grown as previously described [3].
Glycan arrays
Glycan arrays were prepared and performed as previously
described by Day et al. [3] with slight modification to the
preparation of the slides as outlined by Hartley-Tassell
et al. [30] using the glycan library described in Arndt et al.
[3,30,31]. See Additional file 1: Table S1 for full list and
structures of glycans. The arrays were scanned by a
ProScan Array scanner at 488/520 nm and the results
analysed by ScanArray Express software program. Binding
was defined as a value greater than 1 fold increase above
mean background relative fluorescence units (RFU). The
mean background was calculated from the average back-
ground of empty spots on the array plus three standard
deviations. Statistical analysis of the data was performed
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(p ≤ 0.0001). All arrays were performed in triplicate
with a total of 12 data points for each glycan tested.
Lectin competition adherence assays
Adherence and lectin competition assays were perfor-
med as previously described [3], however, only using
C. jejuni grown at 37°C under micraerobic conditions.
E. coli DH5α cells were used as a control for the lectin
competition assays to ensure that reduction in adher-
ence was not due to steric hindrance of the lectins on
the cell surface inhibiting cell binding to non-glycan
targets. Lectins were used at 10 μg per well. All assays
were performed in triplicate.
Free glycan inhibition assay
Adherence assays were performed as previously de-
scribed [3] under conditions described above. Two ex-
emplary strains of C. jejuni were used for this analysis,
the human clinical isolate 11168 and the chicken isolate
331. Free glycan (H-disaccharide, A-blood group antigen
and α1-2 mannobiose) were added to the media at a
final concentration of 100 μM just prior to addition of
the bacteria.
Additional file
Additional file 1: Table of Glycans.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CJD conceived the experiments, performed many of the array and all the cell
culture experiments and aided in the analysis of the data. CJD wrote a
significant portion of the completed manuscript. GT helped perform array
experimentation, aided with the glycan inhibition cell culture assays, helped
analyse data and aided in the production of the manuscript. LEH-T helped
performed array experimentation, helped analyse data including the
establishment of the statistical template and aided in the production of the
manuscript. JT helped performed array experimentation, helped analyse data
and aided in the production of the manuscript. VK conceived the
experiments, aided in the analysis of the data and was responsible for final
edits of the completed manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This work was partially funded by and CJD and LHT are supported by a
Queensland State Government, Department of Science, Information
Technology, Innovation and the Arts Research Partnerships Program. GT is
supported by a Griffith University Postgradute Research Scholarship.
Received: 29 July 2013 Accepted: 27 September 2013
Published: 14 October 2013
Reference
1. Smith DC, Lord JM, Roberts LM, Johannes L: Glycosphingolipids as toxin
receptors. Semin Cell Dev Biol 2004, 15(4):397–408.
2. Lehmann F, Tiralongo E, Tiralongo J: Sialic acid-specific lectins: occurrence,
specificity and function. Cell Mol Life Sci 2006, 63(12):1331–1354.
3. Day CJ, Tiralongo J, Hartnell RD, Logue CA, Wilson JC, von Itzstein M, Korolik
V: Differential carbohydrate recognition by Campylobacter jejuni strain11168: influences of temperature and growth conditions. PLoS One 2009,
4(3):e4927.
4. Day CJ, Semchenko EA, Korolik V: Glycoconjugates play a key role in
campylobacter jejuni infection: interactions between host and pathogen.
Front Cell Infect Microbiol 2012, 2:9.
5. Newburg DS, Ruiz-Palacios GM, Morrow AL: Human milk glycans protect
infants against enteric pathogens. Annu Rev Nutr 2005, 25:37–58.
6. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS: Human-milk glycans
that inhibit pathogen binding protect breast-feeding infants against
infectious diarrhea. J Nutr 2005, 135(5):1304–1307.
7. Yamaoka Y: Roles of Helicobacter pylori BabA in gastroduodenal
pathogenesis. World J Gastroenterol 2008, 14(27):4265–4272.
8. Juge N: Microbial adhesins to gastrointestinal mucus. Trends Microbiol
2012, 20(1):30–39.
9. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J,
Larsson T, Teneberg S, Karlsson KA, et al: Helicobacter pylori SabA adhesin in
persistent infection and chronic inflammation. Science 2002, 297(5581):573–578.
10. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ, Florin TH,
Hill GR, Korolik V, McGuckin MA: MUC1 cell surface mucin is a critical element
of the mucosal barrier to infection. J Clin Invest 2007, 117(8):2313–2324.
11. Varki A: Multiple changes in sialic acid biology during human evolution.
Glycoconj J 2009, 26(3):231–245.
12. Le Pendu J: Histo-blood group antigen and human milk oligosaccharides:
genetic polymorphism and risk of infectious diseases. Adv Exp Med Biol
2004, 554:135–143.
13. Suzuki N, Laskowski M Jr, Lee YC: Phylogenetic expression of Galalpha1-
4Gal on avian glycoproteins: glycan differentiation inscribed in the early
history of modern birds. Proc Natl Acad Sci USA 2004, 101(24):9023–9028.
14. Galili U, Clark MR, Shohet SB, Buehler J, Macher BA: Evolutionary relationship
between the natural anti-Gal antibody and the Gal alpha 1––3Gal epitope
in primates. Proc Natl Acad Sci USA 1987, 84(5):1369–1373.
15. Yang Z, Bergstrom J, Karlsson KA: Glycoproteins with Gal alpha 4Gal are
absent from human erythrocyte membranes, indicating that glycolipids
are the sole carriers of blood group P activities. J Biol Chem 1994,
269(20):14620–14624.
16. Sandrin MS, McKenzie IF: Gal alpha (1,3)Gal, the major xenoantigen(s)
recognised in pigs by human natural antibodies. Immunol Rev 1994,
141:169–190.
17. Garratty G: Blood group antigens as tumor markers, parasitic/bacterial/
viral receptors, and their association with immunologically important
proteins. Immunol Invest 1995, 24(1–2):213–232.
18. Houliston RS, Vinogradov E, Dzieciatkowska M, Li J, St Michael F, Karwaski
MF, Brochu D, Jarrell HC, Parker CT, Yuki N, et al: Lipooligosaccharide of
Campylobacter jejuni: similarity with multiple types of mammalian
glycans beyond gangliosides. J Biol Chem 2011, 286(14):12361–12370.
19. Hald B, Skovgard H, Pedersen K, Bunkenborg H: Influxed insects as vectors
for Campylobacter jejuni and Campylobacter coli in Danish broiler
houses. Poult Sci 2008, 87(7):1428–1434.
20. Schallenberg M, Bremer PJ, Henkel S, Launhardt A, Burns CW: Survival of
Campylobacter jejuni in water: effect of grazing by the freshwater
crustacean Daphnia carinata (Cladocera). Appl Environ Microbiol 2005,
71(9):5085–5088.
21. Holden KM, Gilbert M, Coloe PJ, Li J, Fry BN: The role of WlaRG, WlaTB and
WlaTC in lipooligosaccharide synthesis by Campylobacter jejuni strain
81116. Microb Pathog 2012, 52(6):344–352.
22. St Michael F, Szymanski CM, Li J, Chan KH, Khieu NH, Larocque S, Wakarchuk
WW, Brisson JR, Monteiro MA: The structures of the lipooligosaccharide and
capsule polysaccharide of Campylobacter jejuni genome sequenced strain
NCTC 11168. Eur J Biochem 2002, 269(21):5119–5136.
23. Semchenko EA, Day CJ, Wilson JC, Grice ID, Moran AP, Korolik V:
Temperature-dependent phenotypic variation of Campylobacter jejuni
lipooligosaccharides. BMC Microbiol 2010, 10:305.
24. Semchenko EA, Day CJ, Moutin M, Wilson JC, Tiralongo J, Korolik V:
Structural heterogeneity of terminal glycans in Campylobacter jejuni
lipooligosaccharides. PLoS One 2012, 7(7):e40920.
25. Yamada KM, Kennedy DW, Kimata K, Pratt RM: Characterization of
fibronectin interactions with glycosaminoglycans and identification of
active proteolytic fragments. J Biol Chem 1980, 255(13):6055–6063.
26. Konkel ME, Garvis SG, Tipton SL, Anderson DE Jr, Cieplak W Jr: Identification
and molecular cloning of a gene encoding a fibronectin-binding protein
(CadF) from Campylobacter jejuni. Mol Microbiol 1997, 24(5):953–963.
Day et al. BMC Microbiology 2013, 13:228 Page 12 of 12
http://www.biomedcentral.com/1471-2180/13/22827. Chung CY, Erickson HP: Glycosaminoglycans modulate fibronectin matrix
assembly and are essential for matrix incorporation of tenascin-C. J Cell
Sci 1997, 110(Pt 12):1413–1419.
28. Calderon-Gomez LI, Hartley LE, McCormack A, Ringoir DD, Korolik V:
Potential use of characterised hyper-colonising strain(s) of
Campylobacter jejuni to reduce circulation of environmental strains in
commercial poultry. Vet Microbiol 2009, 134(3–4):353–361.
29. Korolik V, Alderton MR, Smith SC, Chang J, Coloe PJ: Isolation and
molecular analysis of colonising and non-colonising strains of
Campylobacter jejuni and Campylobacter coli following experimental
infection of young chickens. Vet Microbiol 1998, 60(2–4):239–249.
30. Hartley-Tassell LE, Shewell LK, Day CJ, Wilson JC, Sandhu R, Ketley JM,
Korolik V: Identification and characterization of the aspartate
chemosensory receptor of Campylobacter jejuni. Mol Microbiol 2010,
75(3):710–730.
31. Arndt NX, Tiralongo J, Madge PD, von Itzstein M, Day CJ: Differential
carbohydrate binding and cell surface glycosylation of human cancer
cell lines. J Cell Biochem 2011, 112(9):2230–2240.
doi:10.1186/1471-2180-13-228
Cite this article as: Day et al.: Assessment of glycan interactions of
clinical and avian isolates of Campylobacter jejuni. BMC Microbiology
2013 13:228.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
